F V van Daalen1, J M Prins2, B C Opmeer3, M A Boermeester4, C E Visser5, R M van Hest6, J Branger7, E Mattsson8, M F M van de Broek9, T C Roeleveld10, A A Karimbeg11, E A F Haak12, H C van den Hout13, M A van Agtmael14, M E J L Hulscher15, S E Geerlings2. 1. Department of Internal Medicine, Division of Infectious Diseases, Centre for Infection and Immunity Amsterdam, The Netherlands. Electronic address: f.v.vandaalen@amc.nl. 2. Department of Internal Medicine, Division of Infectious Diseases, Centre for Infection and Immunity Amsterdam, The Netherlands. 3. Clinical Research Unit, Academic Medical Centre, Amsterdam, The Netherlands. 4. Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands. 5. Department of Microbiology, Academic Medical Centre, Amsterdam, The Netherlands. 6. Department of Pharmacy, Academic Medical Centre, Amsterdam, The Netherlands. 7. Department of Internal Medicine, Flevoziekenhuis, Almere, The Netherlands. 8. Department of Medical Microbiology, Reinier de Graaf, Delft, The Netherlands. 9. Department of Internal Medicine, Antoniusziekenhuis, Nieuwegein, The Netherlands. 10. Department of Internal Medicine, Spaarnegasthuis, Hoofddorp, The Netherlands. 11. Department of Internal Medicine, Westfriesgasthuis, Hoorn, The Netherlands. 12. Department of Hospital Pharmacy, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. 13. Department of Internal Medicine, Spaarnegasthuis, Haarlem, The Netherlands. 14. Department of Internal Medicine, Division of Infectious Diseases, VU Medical Centre, Amsterdam, The Netherlands. 15. Department of Scientific Institute for Quality of Healthcare (IQ healthcare), Radboud University Medical Centre, Nijmegen, The Netherlands.
Abstract
OBJECTIVES: Quality indicators (QIs) have been developed to define appropriate antibiotic use in hospitalized patients. We evaluated whether a checklist based on these QIs affects appropriate antibiotic use and length of hospital stay. METHODS: An antibiotic checklist for patients treated with intravenous antibiotics was introduced in nine Dutch hospitals in a stepped wedge cluster randomized trial. Prophylaxis was excluded. We included a random sample before (baseline), and all eligible patients after (intervention) checklist introduction. Baseline and intervention outcomes were compared. Primary endpoint was length of stay (LOS), analysed by intention to treat. Secondary endpoints, including QI performances, QI sum score (performance on all QIs per patient), and quality of checklist use, were analysed per protocol. RESULTS:Between 1 November 2014 and 1 October 2015 we included 853 baseline and 5354 intervention patients, of whom 993 (19%) had a completed checklist. The LOS did not change (baseline geometric mean 10.0 days (95% CI 8.6-11.5) versus intervention 10.1 days (95% CI 8.9-11.5), p 0.8). QI performances increased between +3.0% and +23.9% per QI, and the percentage of patients with a QI sum score above 50% increased significantly (OR 2.4 (95% CI 2.0-3.0), p<0.001). Higher QI sum scores were significantly associated with shorter LOS. Discordance existed between checklist-answers and actual performance. CONCLUSIONS: Use of an antibiotic checklist resulted in a significant increase in appropriateness of antibiotic use, but not in a reduction of LOS. Low overall checklist completion rates and discordance between checklist-answers and actual provided care might have attenuated the impact of the checklist.
RCT Entities:
OBJECTIVES: Quality indicators (QIs) have been developed to define appropriate antibiotic use in hospitalized patients. We evaluated whether a checklist based on these QIs affects appropriate antibiotic use and length of hospital stay. METHODS: An antibiotic checklist for patients treated with intravenous antibiotics was introduced in nine Dutch hospitals in a stepped wedge cluster randomized trial. Prophylaxis was excluded. We included a random sample before (baseline), and all eligible patients after (intervention) checklist introduction. Baseline and intervention outcomes were compared. Primary endpoint was length of stay (LOS), analysed by intention to treat. Secondary endpoints, including QI performances, QI sum score (performance on all QIs per patient), and quality of checklist use, were analysed per protocol. RESULTS: Between 1 November 2014 and 1 October 2015 we included 853 baseline and 5354 intervention patients, of whom 993 (19%) had a completed checklist. The LOS did not change (baseline geometric mean 10.0 days (95% CI 8.6-11.5) versus intervention 10.1 days (95% CI 8.9-11.5), p 0.8). QI performances increased between +3.0% and +23.9% per QI, and the percentage of patients with a QI sum score above 50% increased significantly (OR 2.4 (95% CI 2.0-3.0), p<0.001). Higher QI sum scores were significantly associated with shorter LOS. Discordance existed between checklist-answers and actual performance. CONCLUSIONS: Use of an antibiotic checklist resulted in a significant increase in appropriateness of antibiotic use, but not in a reduction of LOS. Low overall checklist completion rates and discordance between checklist-answers and actual provided care might have attenuated the impact of the checklist.
Authors: M C Kallen; M E J L Hulscher; B Elzer; S E Geerlings; P D van der Linden; S Teerenstra; S Natsch; B C Opmeer; J M Prins Journal: J Antimicrob Chemother Date: 2021-05-12 Impact factor: 5.790
Authors: Frederike V van Daalen; Marlies E J L Hulscher; Cas Minderhoud; Jan M Prins; Suzanne E Geerlings Journal: BMC Infect Dis Date: 2018-01-08 Impact factor: 3.090
Authors: F V van Daalen; M C Kallen; C M A van den Bosch; M E J L Hulscher; S E Geerlings; J M Prins Journal: Eur J Clin Microbiol Infect Dis Date: 2017-06-07 Impact factor: 3.267
Authors: Saskia J Bogers; Frederike V van Daalen; Sacha D Kuil; Menno D de Jong; Suzanne E Geerlings Journal: Eur J Clin Microbiol Infect Dis Date: 2019-03-07 Impact factor: 3.267
Authors: Seven Johannes Sam Aghdassi; Frank Schwab; Sonja Hansen; Luis Alberto Peña Diaz; Michael Behnke; Petra Gastmeier; Tobias Siegfried Kramer Journal: Euro Surveill Date: 2019-11
Authors: Bart J Laan; Willemijn B Huiszoon; Frits Holleman; Marja A Boermeester; Karin A H Kaasjager; Suzanne E Geerlings Journal: BMJ Open Qual Date: 2021-02
Authors: Saskia J Bogers; Maarten F Schim van der Loeff; Anders Boyd; Udi Davidovich; Marc van der Valk; Kees Brinkman; Kim Sigaloff; Judith Branger; Nejma Bokhizzou; Godelieve J de Bree; Peter Reiss; Jan E A M van Bergen; Suzanne E Geerlings Journal: Lancet Reg Health Eur Date: 2022-10-07
Authors: Bongyoung Kim; Myung Jin Lee; Se Yoon Park; Song Mi Moon; Kyoung-Ho Song; Tae Hyong Kim; Eu Suk Kim; Hong Bin Kim Journal: Antimicrob Resist Infect Control Date: 2021-03-06 Impact factor: 4.887